These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9765493)

  • 1. Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.
    Karnauchow TM; Dawe S; Lublin DM; Dimock K
    J Virol; 1998 Nov; 72(11):9380-3. PubMed ID: 9765493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).
    Karnauchow TM; Tolson DL; Harrison BA; Altman E; Lublin DM; Dimock K
    J Virol; 1996 Aug; 70(8):5143-52. PubMed ID: 8764022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses: implications for the evolution of a DAF-binding phenotype.
    Powell RM; Ward T; Goodfellow I; Almond JW; Evans DJ
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3145-3152. PubMed ID: 10567645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).
    Manchester M; Valsamakis A; Kaufman R; Liszewski MK; Alvarez J; Atkinson JP; Lublin DM; Oldstone MB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2303-7. PubMed ID: 7534417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation.
    Christiansen D; Loveland B; Kyriakou P; Lanteri M; Rubinstein E; Gerlier D
    Mol Immunol; 2000; 37(12-13):687-96. PubMed ID: 11275254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.
    Shafren DR; Dorahy DJ; Ingham RA; Burns GF; Barry RD
    J Virol; 1997 Jun; 71(6):4736-43. PubMed ID: 9151867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
    Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
    J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.
    Haddad A; Nokhbeh MR; Alexander DA; Dawe SJ; Grisé C; Gulzar N; Dimock K
    J Virol; 2004 Mar; 78(6):2674-81. PubMed ID: 14990687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.
    Spiller OB; Goodfellow IG; Evans DJ; Hinchliffe SJ; Morgan BP
    J Gen Virol; 2002 Jan; 83(Pt 1):45-52. PubMed ID: 11752699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.
    Powell RM; Ward T; Evans DJ; Almond JW
    J Virol; 1997 Dec; 71(12):9306-12. PubMed ID: 9371589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).
    Giannakis E; Jokiranta TS; Ormsby RJ; Duthy TG; Male DA; Christiansen D; Fischetti VA; Bagley C; Loveland BE; Gordon DL
    J Immunol; 2002 May; 168(9):4585-92. PubMed ID: 11971006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the active sites in decay-accelerating factor.
    Kuttner-Kondo LA; Mitchell L; Hourcade DE; Medof ME
    J Immunol; 2001 Aug; 167(4):2164-71. PubMed ID: 11490001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein.
    Hsu EC; Sabatinos S; Hoedemaeker FJ; Rose DR; Richardson CD
    Virology; 1999 Jun; 258(2):314-26. PubMed ID: 10366568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2.
    Manchester M; Gairin JE; Patterson JB; Alvarez J; Liszewski MK; Eto DS; Atkinson JP; Oldstone MB
    Virology; 1997 Jun; 233(1):174-84. PubMed ID: 9201227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function.
    Greenstone HL; Santoro F; Lusso P; Berger EA
    J Biol Chem; 2002 Oct; 277(42):39112-8. PubMed ID: 12171934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.
    Shafren DR; Dorahy DJ; Thorne RF; Kinoshita T; Barry RD; Burns GF
    J Immunol; 1998 Mar; 160(5):2318-23. PubMed ID: 9498772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of decay-accelerating factor (DAF) with haemagglutinating human enteroviruses: utilizing variation in primate DAF to map virus binding sites.
    Williams DT; Chaudhry Y; Goodfellow IG; Lea S; Evans DJ
    J Gen Virol; 2004 Mar; 85(Pt 3):731-738. PubMed ID: 14993659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.
    Clarkson NA; Kaufman R; Lublin DM; Ward T; Pipkin PA; Minor PD; Evans DJ; Almond JW
    J Virol; 1995 Sep; 69(9):5497-501. PubMed ID: 7543583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.
    Newcombe NG; Johansson ES; Au G; Lindberg AM; Barry RD; Shafren DR
    J Virol; 2004 Feb; 78(3):1431-9. PubMed ID: 14722298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.
    Yoder JD; Cifuente JO; Pan J; Bergelson JM; Hafenstein S
    J Virol; 2012 Dec; 86(23):12571-81. PubMed ID: 22973031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.